Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310362 · ClinicalTrials.gov registry record · NA
Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 3,610
- Enrollment target
NCT00310362: Completed NA study, sponsored by VA Office of Research and Development.
NCT00310362 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 3,610 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (157% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00310362, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,610 participants
- Enrollment target
Study Summary
Low endoscopy completion rates are a major problem in the VA, causing delay or failure to receive essential care, increased clinic wait times, lost capacity, increased costs, thus limiting endoscopic screening for colorectal cancer. This study tests whether an Interactive Voice Response (IVR) messaging system is equally effective in promoting the completion of flexible sigmoidoscopy and colonoscopy as usual clinical care practices that include phone calls from nurses to patients prior to preparation and procedures. Previous studies have examined the role of scheduling facilitation or patient adherence on endoscopy completion and the use of IVR technology to enhance patient adherence in other medical contexts. This is the first study, however, to evaluate the use of IVR for endoscopy completion and the first to compare it to the effectiveness of phone calls from nurses prior to an endoscopy appointment.
Primary Outcome
Nonattendance was defined as canceling the colonoscopy appointment or not attending the appointment
Interventions
- BEHAVIORAL Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,610 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00310362 record still lists
NCT00310362 is an interventional study that assigns participants to a tested intervention. Its 3,610 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (157% higher).
The record links to 0 conditions, and to 1 intervention - of which Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures is the first listed.
NCT00310362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00310362 about?
NCT00310362 is a clinical study titled "Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates". Low endoscopy completion rates are a major problem in the VA, causing delay or failure to receive essential care, increased clinic wait times, lost capacity, increased costs, thus limiting endoscopic screening for colorectal cancer. This study tests whether an Interactive Voice Response (IVR) messag...
What is the current status of trial NCT00310362?
This trial is currently completed. It is a NA study. The enrollment target is 3,610 participants. The study started on 2007-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00310362?
The interventions under investigation include: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT00310362?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00310362's enrollment target sits among peer trials
3,610 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia